Pathology lab values are meaningless - in isolation to the clinical context
The moment they receive reports, patients start searching right away on Google or chatGPT. They end up getting more confused.
1. In many tests, values differ by age, gender
Many laboratory values vary significantly by age and sex, making it essential to compare results against appropriate demographic-specific reference ranges rather than universal standards. Four key examples illustrate this principle:
Haemoglobin (Hgb)
Adult ranges: Males 13.8–17.2 g/dL, Females 12.1–15.1 g/dL
Newborns: 14–24 g/dL; Infants (6–12 weeks): ~9–11 g/dL (physiologic nadir)
Newborns have elevated foetal haemoglobin, whilst adult females typically show lower values due to menstrual blood loss and reduced muscle mass. Always compare to age and sex-specific references alongside clinical symptoms such as fatigue or tachycardia.
Alkaline Phosphatase (ALP)
Adult range: ~44–147 U/L (laboratory-dependent)
Children/adolescents: Commonly in the hundreds during growth phases
Bone-derived ALP rises substantially during periods of growth or increased bone turnover. Pregnancy also elevates ALP levels. In adults, elevated ALP requires isoenzyme context (GGT) to distinguish between bone and hepatic sources.
Serum Creatinine
Adult ranges: Males 0.6–1.2 mg/dL, Females 0.5–1.1 mg/dL
Children/infants: Lower (e.g., 0.3–0.7 mg/dL)
Creatinine production correlates with muscle mass, resulting in lower values in small children, elderly patients, and females, whilst muscular men show higher values. Always use eGFR and compare to baseline, as small absolute rises may indicate acute kidney injury in low-muscle patients.
Prostate-Specific Antigen (PSA)
Age-adjusted guidance:
- 40–49 years: ≤2.5 ng/mL
- 50–59 years: ≤3.5 ng/mL
- 60–69 years: ≤4.5 ng/mL
- 70–79 years: ≤6.5 ng/mL
PSA rises with age due to benign prostatic hyperplasia and other causes. The same PSA value is more concerning in younger men. Interpret alongside digital rectal examination, trends, and PSA velocity.
2. In some tests small deviations might be critical
Not all laboratory deviations carry equal clinical weight. Small changes in certain analytes can be life-threatening, whilst similar deviations in others may be clinically insignificant. Understanding these distinctions is crucial for appropriate clinical response.
3. A deviation only on one side is important
For certain laboratory tests, deviation in one direction carries far greater clinical significance than deviation in the opposite direction. Gamma-glutamyl transferase (GGT) exemplifies this principle perfectly.
GGT as a Hepatic Marker
Typical range: <50 U/L (laboratory-dependent)
Elevated GGT significance: Supports hepatobiliary injury, cholestasis, or enzyme induction from alcohol or drugs. Particularly useful for confirming hepatic origin when ALP is raised.
Low/normal GGT significance: Usually not diagnostically important and carries minimal clinical weight.
Clinical Vignette: Asymmetry in Action
Scenario A: ALP 320 U/L with GGT 210 U/L → Favours cholestatic liver or biliary disease. Requires urgent imaging and hepatobiliary workup.
Scenario B: ALP 320 U/L with GGT 18 U/L → Favours bone source (growth, fracture, vitamin D deficiency). Different workup entirely, focusing on bone metabolism.
Actionable point: Elevated GGT is actionable and diagnostic; normal or low GGT steers diagnosis away from hepatic pathology.
4. Deviations might be incidental or systemic
The same laboratory abnormality can represent either a benign, incidental finding or a dangerous systemic condition requiring urgent intervention. Context, magnitude, and associated findings determine the appropriate clinical response.
Incidental Example: Bone-Source ALP Elevation
Presentation: ALP 160–300 U/L with normal GGT in an otherwise well young adult
Interpretation: Bone source (growth, fracture, vitamin D deficiency)
Management: Outpatient approach with vitamin D supplementation, bone markers, and imaging if clinically indicated. No urgency required.
Systemic Example: Cholestatic Obstruction
Presentation: ALP ~500 U/L with GGT ~400 U/L, accompanied by jaundice and pale stools
Interpretation: Cholestatic obstruction (biliary obstruction, cholangitis, or malignancy)
Management: Urgent imaging and likely hospital admission with intervention. Potentially life-threatening condition.
Key discriminators: Magnitude of elevation, GGT concordance, bilirubin and INR levels, clinical symptoms (jaundice, pruritus), and imaging findings all help distinguish incidental from systemic pathology.
5. Some values fluctuate really fast vs others
Laboratory tests vary dramatically in their temporal dynamics. Understanding whether a test changes over hours, days, or months is essential for appropriate monitoring intervals and clinical decision-making.
1
Slow-Changing (Months)
HbA1c: Reflects approximately 3 months of average glucose levels (RBC lifespan ~120 days). Example: A1c 8.5% decreases to ~7.5% over 8–12 weeks with therapy.
Implication: Don't recheck HbA1c after days; wait 8–12 weeks to properly judge therapeutic response.
2
Mixed Kinetics
Serum Creatinine: Chronic trends change slowly in CKD, but acute kidney injury can develop over hours to days (KDIGO criterion ≥0.3 mg/dL within 48 hours).
Implication: Always compare to prior baseline and monitor trajectory carefully in acute settings.
3
Fast-Fluctuating (Minutes–Days)
Potassium: Shifts rapidly with meals, insulin, acid-base status, and cell lysis.
WBC & CRP: Rise within hours to days with infection; CRP peaks at 24–48 hours and falls with resolution.
Troponin (hs-cTn): Rises within hours of myocardial injury; requires serial sampling for rise/fall pattern to diagnose MI.
Implication: Confirm unexpected values immediately, check ECG for potassium, repeat inflammatory markers every 24–72 hours, and obtain serial troponins at protocolised intervals (0/1–3 hours).
6. Timing & stage of sampling affect interpretation
The timing of sample collection relative to disease onset, physiological cycles, or symptom development profoundly affects test interpretation. Three key examples demonstrate this principle:
Pregnancy (β-hCG)
Timeline: Implantation → hCG production begins ~6–10 days post-conception. Serum β-hCG detects pregnancy ~7–10 days post-conception; urine tests reliable from ~10–14 days or by missed period. hCG roughly doubles every ~48 hours early on.
Why timing matters: A negative very-early urine test does not exclude pregnancy. Use quantitative serum testing and repeat in 48 hours if clinical suspicion persists.
FSH/LH (Menstrual Cycle & Menopause)
Typical ranges (female):
- FSH: Follicular 1.4–9.9 IU/L, Ovulatory peak 6–17 IU/L, Luteal 1.1–9.2 IU/L, Post-menopause 19–100+ IU/L
- LH: Follicular 1–15 IU/L, Mid-cycle surge 20–60+ IU/L, Luteal low again
Why timing matters: A single value without cycle day context is misleading. FSH 25 IU/L is normal post-menopause but suggests premature ovarian insufficiency in a 30-year-old woman.
Dengue (NS1/PCR vs IgM)
Detection windows: NS1/PCR optimal early (days 0–5–7 after symptom onset); IgM usually detectable from day ~4–5 onwards.
Why timing matters: NS1 negative on day 6 does not rule out dengue; IgM negative on days 2–3 is expected. If clinical suspicion remains high, repeat with IgM testing after 48–72 hours or use paired serology.
